{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/INSM",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# INSMED Inc (NASDAQ: INSM) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is INSMED Inc, listed on NASDAQ under ticker INSM, with ISIN US4576693075 and LEI 529900Q55QAG41CCAC11. The security type is Corporate and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Virginia. The segment is not on the record. The status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 183 filings in the window 2025-11-08 to 2026-11-08, across 93 filing days. The median gap between filing days is 2.0 days. The latest filing is dated 2026-11-03, and it is of type directors_dealings. Five days separate the latest filing from the record date of 2026-11-08. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days, and a latency of 5.0 days across 4359 issuers. The sector median is 63.0 filings, a cadence gap of 6.0 days, and a latency of 4.0 days across 526 issuers.\n\n## Auditor\n\nThe auditor of record is Ernst & Young LLP, located in Iselin, New Jersey. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 26 research houses: Barclays, BMO Capital Markets, BofA Securities, Cantor, Evercore ISI, Goldman Sachs, Guggenheim Securities, H.C. Wainwright & Co., Jefferies, J.P. Morgan, Leerink Partners, Mizuho Securities, Morgan Stanley, Raymond James, RBC Capital Markets, Roth Capital Partners, Rothschild & Co., Redburn, Stifel, TD Cowen and Company, Truist Securities, UBS, Wells Fargo, William Blair, Wolfe Research and Saunders.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe record holds the issuer as sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001104506.json (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/INSM (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1104506/000110450626000009/insm-20251231.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://investor.insmed.com/analysts (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/INSM (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1104506/000110450626000009/insm-20251231.htm",
    "state": "sourced",
    "value": "Ernst & Young LLP"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1104506/000110450626000009/insm-20251231.htm",
    "state": "sourced",
    "value": "42"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1104506/000110450626000009/insm-20251231.htm",
    "state": "sourced",
    "value": "Iselin, New Jersey"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/INSM",
  "coverage": {
   "count": 26,
   "houses": [
    {
     "analyst": "Eliana Merle",
     "house": "Barclays",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Conor MacKay",
     "house": "BMO Capital Markets",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Jason Zemansky",
     "house": "BofA Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Olivia Brayer Saunders",
     "house": "Cantor",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Gavin Clark-Gartner",
     "house": "Evercore ISI",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Andrea Newkirk",
     "house": "Goldman Sachs",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Vamil Divan",
     "house": "Guggenheim Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Matthew Caufield",
     "house": "H.C. Wainwright & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Faisal Khurshid",
     "house": "Jefferies",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Jessica Fye",
     "house": "J.P. Morgan",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Joseph P. Schwartz",
     "house": "Leerink Partners",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Graig Suvannavejh",
     "house": "Mizuho Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Maxwell Skor",
     "house": "Morgan Stanley",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Tiago Fauth",
     "house": "Raymond James",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Leonid Timashev",
     "house": "RBC Capital Markets",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Adam Walsh",
     "house": "Roth Capital Partners",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "house": "Rothschild & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Qize Ding",
     "house": "Redburn",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Stephen D. Willey",
     "house": "Stifel",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Ritu Baral",
     "house": "TD Cowen and Company",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Danielle Brill",
     "house": "Truist Securities",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Ashwani Verma",
     "house": "UBS",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Benjamin Burnett",
     "house": "Wells Fargo",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Matt Phipps",
     "house": "William Blair",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "house": "Wolfe Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    },
    {
     "house": "Saunders",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investor.insmed.com/analysts",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://investor.insmed.com/analysts",
     "result": "read: 26 of 50 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "agm_egm": 3,
    "corporate_news": 6,
    "director_change": 2,
    "directors_dealings": 80,
    "prospectus": 1,
    "regulatory_filing": 83,
    "results": 8
   },
   "cadence_median_gap_days": 2,
   "filing_days": 93,
   "filings": 183,
   "latency_days": 5,
   "latest": [
    {
     "category": "3",
     "date": "2026-11-03",
     "source": "https://www.sec.gov/Archives/edgar/data/1104506/000216217726000003/xslF345X06/wk-form3_1793740440.xml",
     "title": "3 — FORM 3",
     "type": "directors_dealings"
    },
    {
     "category": "144",
     "date": "2026-11-03",
     "source": "https://www.sec.gov/Archives/edgar/data/1104506/000162828026069586/xsl144X01/primary_doc.xml",
     "title": "144",
     "type": "regulatory_filing"
    },
    {
     "category": "8-K",
     "date": "2026-10-29",
     "source": "https://www.sec.gov/Archives/edgar/data/1104506/000114036126041097/ef20084500_8k.htm",
     "title": "8-K — 8-K (items 2.02,9.01)",
     "type": "results"
    },
    {
     "category": "10-Q",
     "date": "2026-10-29",
     "source": "https://www.sec.gov/Archives/edgar/data/1104506/000110450626000047/insm-20260930.htm",
     "title": "10-Q — 10-Q",
     "type": "results"
    },
    {
     "category": "4",
     "date": "2026-10-20",
     "source": "https://www.sec.gov/Archives/edgar/data/1104506/000215840826000007/xslF345X06/wk-form4_1792530457.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    }
   ],
   "latest_filing_date": "2026-11-03",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/INSM",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-13",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US4576693075"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001104506.json",
    "state": "sourced",
    "value": "United States — Virginia"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN US4576693075)",
    "state": "sourced",
    "value": "529900Q55QAG41CCAC11"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001104506.json",
    "state": "sourced",
    "value": "INSMED Inc"
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001104506.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001104506.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "INSM"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:9dfefd4d9e7cabe96274f6c42f15da279e083ab46185f461a5cec52150aeefb3",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/INSM",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:9dfefd4d9e7cabe96274f6c42f15da279e083ab46185f461a5cec52150aeefb3",
 "path": "/us/NASDAQ/INSM",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is INSMED Inc, listed on NASDAQ under ticker INSM, with ISIN US4576693075 and LEI 529900Q55QAG41CCAC11. The security type is Corporate and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Virginia. The segment is not on the record. The status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 183 filings in the window 2025-11-08 to 2026-11-08, across 93 filing days. The median gap between filing days is 2.0 days. The latest filing is dated 2026-11-03, and it is of type directors_dealings. Five days separate the latest filing from the record date of 2026-11-08. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days, and a latency of 5.0 days across 4359 issuers. The sector median is 63.0 filings, a cadence gap of 6.0 days, and a latency of 4.0 days across 526 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Ernst & Young LLP, located in Iselin, New Jersey. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 26 research houses: Barclays, BMO Capital Markets, BofA Securities, Cantor, Evercore ISI, Goldman Sachs, Guggenheim Securities, H.C. Wainwright & Co., Jefferies, J.P. Morgan, Leerink Partners, Mizuho Securities, Morgan Stanley, Raymond James, RBC Capital Markets, Roth Capital Partners, Rothschild & Co., Redburn, Stifel, TD Cowen and Company, Truist Securities, UBS, Wells Fargo, William Blair, Wolfe Research and Saunders.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The record holds the issuer as sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001104506.json"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/INSM"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1104506/000110450626000009/insm-20251231.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://investor.insmed.com/analysts"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/INSM"
  }
 ],
 "title": "INSMED Inc (INSM) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}